Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients

scientific article published on 29 July 2020

Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S13071-020-04262-4
P932PMC publication ID7391663
P698PubMed publication ID32727548

P2093author name stringManuela Schnyder
Csilla Becskei
Sean P Mahabir
Magda Wozniakiewicz
Jakob L Willesen
Nataliya Miroshnikova
P2860cites workIncreased prevalence and geographic spread of the cardiopulmonary nematode Angiostrongylus vasorum in fox populations in Great BritainQ30961845
Elusive Angiostrongylus vasorum infectionsQ33425429
Canine pulmonary angiostrongylosis: the influence of climate on parasite distributionQ33493750
Hyperfibrinolysis and Hypofibrinogenemia Diagnosed With Rotational Thromboelastometry in Dogs Naturally Infected With Angiostrongylus vasorumQ33900112
Angiostrongylus vasorum infection in 2 dogs from NewfoundlandQ33963291
Recent advances in the epidemiology, clinical and diagnostic features, and control of canine cardio-pulmonary angiostrongylosisQ34304148
First report of Angiostrongylus vasorum and Hepatozoon from a red fox (Vulpes vulpes) from West Virginia, USA.Q35084909
Canine pulmonary angiostrongylosis: an updateQ37052391
Evaluation of a rapid device for serological in-clinic diagnosis of canine angiostrongylosisQ37607367
GIS-supported epidemiological analysis on canine Angiostrongylus vasorum and Crenosoma vulpis infections in GermanyQ37671415
Angiostrongylus vasorum infection in dogs: Presentation and risk factors.Q38443509
Angiostrongylus vasorum, "The French Heartworm": a Serological Survey in Dogs from France Introduced by a Brief Historical ReviewQ39440850
Comparison of coprological, immunological and molecular methods for the detection of dogs infected with Angiostrongylus vasorum before and after anthelmintic treatmentQ41189550
First report of a fatal autochthonous canine Angiostrongylus vasorum infection in BelgiumQ41634088
Clinical, laboratory and pathological findings in dogs experimentally infected with Angiostrongylus vasorumQ42941003
Autochtonous infection of dogs and slugs with Angiostrongylus vasorum in HungaryQ43593134
Elucidating the spread of the emerging canid nematode Angiostrongylus vasorum between Palaearctic and Nearctic ecozonesQ43643914
Angiostrongylus vasorum infection in 23 dogs (1999-2002).Q45087249
Angiostrongylus vasorum in Great Britain: a nationwide postal questionnaire survey of veterinary practicesQ45252234
Lungworm infections (Angiostrongylus vasorum, Crenosoma vulpis, Aelurostrongylus abstrusus) in dogs and cats in Germany and Denmark in 2003-2007.Q50548626
Canine angiostrongylosis: the French heartworm: an emerging threat in North America.Q53115210
Angiostrongylus vasorum and Aelurostrongylus abstrusus: Neglected and underestimated parasites in South America.Q54942945
First autochthonous case of canine Angiostrongylus vasorum in SlovakiaQ57001469
Detection of specific antibodies in dogs infected with Angiostrongylus vasorumQ59925187
An ELISA for sensitive and specific detection of circulating antigen of Angiostrongylus vasorum in serum samples of naturally and experimentally infected dogsQ59925399
Haematological and biochemical changes in dogs naturally infected with Angiostrongylus vasorum before and after treatmentQ62381939
Natural infections of Crenosoma vulpis and Angiostrongylus vasorum in dogs in Atlantic Canada and their treatment with milbemycin oximeQ80360935
Occurrence of fatal canine Angiostrongylus vasorum infection in ItalyQ80539606
Autochthonous Angiostrongylus vasorum infection in dogs in The NetherlandsQ83515340
Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against four common tick species infesting dogs in EuropeQ89954503
Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USAQ89954509
Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio™) for the prevention of experimental Angiostrongylus vasorum infection in dogsQ89954556
Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in EuropeQ89954560
Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogsQ90042773
First report of Angiostrongylus vasorum in coyotes in mainland North AmericaQ90258310
Occurrence of canine and feline extra-intestinal nematodes in key endemic regions of ItalyQ92280194
P433issue1
P921main subjectangiostrongylosisQ124001586
P304page(s)385
P577publication date2020-07-29
P1433published inParasites and VectorsQ7135941
P1476titleField safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients
P478volume13

Search more.